Zobrazeno 1 - 10
of 55
pro vyhledávání: '"J. E. Landegent"'
Autor:
W. F. J. Veenhof, F. H. M. Cluitmans, R. Willemze, J. E. Landegent, J.H.F. Falkenburg, B. H. J. Esendam
Publikováno v:
Annals of Hematology. 75:201-205
To analyze the role of hematopoietic growth factors (HGFs) and other cytokines in the regulation of hematopoiesis in vivo, we investigated HGFs and cytokine gene expression in appendices obtained from patients who underwent surgery for suspected appe
Autor:
J. E. Landegent, J. Joseph Melenhorst, Roelof Willemze, L Struyk, Willem E. Fibbe, P J van der Elsen
Publikováno v:
British Journal of Haematology. 96:85-91
Acquired aplastic anaemia (AA) represents a state of bone marrow (BM) failure which is characterized by BM hypocellularity and pancytopenia. It has been hypothesized that in some AA patients, bone marrow failure is secondary to the targeted destructi
Publikováno v:
British Journal of Haematology. 94:236-241
Expression profiles were generated for the haemopoietic tyrosine kinase receptors (HGF-TKRs or class III TKRs) by PCR on cDNA samples (RT-PCR) using a degenerate primer set. Each profile consisted of primary and secondary, i.e. enriched for less-expr
Autor:
J. H. F. Falkenburg, J. E. Landegent, Johanna Kluin-Nelemans, Roelof Willemze, L. van de Corput, J. Joseph Melenhorst, Michel G.D. Kester
Publikováno v:
Blood. 87:3795-3802
Hairy cell leukemia (HCL) is characterized by a severe T-cell-mediated immune deficiency. At the same time, spontaneous T-cell activation is noted when splenic T cells are studied in vivo and in vitro. Therefore, we searched for oligoclonal T-cell po
Publikováno v:
Annals of Hematology. 71:41-47
The deoxycytidine kinase (dck) gene encodes the enzyme responsible for the metabolic activation of the antileukemic drugs cytosine arabinoside (AraC) and 5-aza-2'-deoxycytidine (decitabine, DAC). The dck locus was analyzed at the chromosomal and the
Autor:
W. H. Honders, J. E. Landegent, Roelof Willemze, V. W. T. Ruiz Van Haperen, A. P. A. Stegmann
Publikováno v:
Blood. 85:1188-1194
The AraC-resistant rat leukemic cell line RO/1-A has been shown to have a typical deoxycytidine kinase (DCK)-deficient phenotype and cannot metabolize the antileukemic drugs cytarabine (AraC) and decitabine (DAC). To investigate the relative contribu
Autor:
R. Boulieu, A. Lenoir, J. F. Mornex, C. Bohman, J. Balzarini, P. Wigerinck, A. Aerschot, P. Herdewijn, Erik Clercq, S. Brosh, E. Zoref-Shani, O. Sperling, E. Danziger, Y. Sidi, Y. Bromberg, Renate Burgemeister, Elke Rötzer, Wolf Gutensohn, G. P. Connolly, P. J. Harrison, R. B. Diasio, Z. Lu, R. Zhang, U. Gresser, W. Gutensohn, R. Resta, L. F. Thompson, F. Javaux, M. F. Vincent, G. Berghe, I. Kamilli, R. Rauch, D. Hahn, C. W. Keuzenkamp-Jansen, R. A. Abreu, J. P. M. Bökkerink, M. A. H. Heijden, M. Löffler, C. Becker, E. Wegerie, M. Marcussen, K. Overgaard-Hansen, H. Klenow, A. M. Marinaki, E. H. Harley, M. B. McBride, H. A. Simmonds, F. Moro, J. S. Cameron, C. S. Ogg, D. G. Williams, S. Rigden, G. Haycock, M. E. Miranda, J. G. Puig, F. A. Mateos, J. O. Vázquez, V. W. T. Ruiz Haperen, G. Veerman, J. B. Vermorken, G. J. Peters, C. L. Wilt, P. Noordhuis, K. Smid, H. M. Pinedo, C. Salerno, A. Lomonte, O. Giardini, C. Crifo, R. T. Smolenski, M. H. Yacoub, A. M. -L. Seymour, A. P. A. Stegmann, M. W. Honders, R. Willemze, J. E. Landegent, E. H. Stet, G. M. Vogels-Mentink, L. H. J. Lambooy, J. M. F. Trijbels, R. J. Torres, M. G. Tozzi, R. Pesi, M. Turriani, S. Allegrini, M. Camici, P. L. Ipata, A. A. Berg, J. R. Meinsma, H. Lenthe, A. H. Gennip, A. B. P. Kuilenburg, N. G. G. M. Abeling, H. D. Bakker, R. J. Slingerland, F. Bergh, R. L. Sabina
Publikováno v:
Pharmacy World & Science. 15:F7-F14
Autor:
R. Willemze, J. E. Landegent, H. Van Kamp, R. Mout, M. J. P. L. Kroef, J. W. Wessels, W. E. Fibbe, R. P. M. Jansen, H.L. Haak
Publikováno v:
Blood. 81:1849-1854
Interstitial deletions of the long arm of chromosome 5 are among the most characteristic abnormalities observed in myeloid disorders. To assess the lineage involvement of peripheral blood cells from patients with a 5q--anomaly, purified neutrophils,
Autor:
Willem E. Fibbe, E. De Graaff, H. Van Kamp, R. P. M. Jansen, J. E. Landegent, M. Van Der Keur, Roelof Willemze
Publikováno v:
Blood. 80:1774-1780
To determine the clonal nature of hematopoiesis and to assess lineage involvement in patients with myelodysplastic syndromes (MDS), we used restriction fragment length polymorphisms of the X-linked genes phosphoglycerate kinase (PGK1) and hypoxanthin
Autor:
M. Verlaan-De Vries, W. E. Fibbe, C. De Pijper, J. E. Landegent, Johannes L. Bos, R. Willemze, C. H. W. Leeksma, H. Van Kamp, H. Kerkhofs
Publikováno v:
Blood. 79:1266-1270
We performed a longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia and a follow-up of at least 2.5 years after diagnosis. Point mutations at codons 12, 13, and 61 of the N-ras oncogene were analyzed af